Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023

GlobeNewswire February 14, 2023

DIAGNOS Announces Grant of Stock Options

GlobeNewswire February 10, 2023

DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals

GlobeNewswire January 31, 2023

DIAGNOS (TSXV:ADK) closes $250K financing

Caroline Egan  January 13, 2023

DIAGNOS Announces Closing of Private Placement

GlobeNewswire January 13, 2023

DIAGNOS Provides Additional Information to the Closing of Private Placement

GlobeNewswire December 15, 2022

DIAGNOS (TSXV:ADK) closes private placement

John Ballem  December 13, 2022

DIAGNOS Announces Closing of Private Placement

GlobeNewswire December 12, 2022

Diagnos (TSXV:ADK) closes non-brokered private placement

Shoran Devi November 25, 2022

DIAGNOS Announces Closing of Private Placement

GlobeNewswire November 25, 2022

Diagnos (TSXV:ADK) enters the retinal diagnostics market with its new 3D image analysis technology

Shoran Devi October 27, 2022

DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology

GlobeNewswire October 27, 2022

DIAGNOS Inc. (TSXV:ADK) closes private placement

John Ballem  September 1, 2022

DIAGNOS Announces Closing of Private Placement

GlobeNewswire September 1, 2022

Diagnos (TSXV:ADK) receives approval for its AI enabled Pathology Detection Systems

Sabrina Cuthbert August 18, 2022

DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems

GlobeNewswire August 18, 2022

DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics

GlobeNewswire July 27, 2022

Diagnos (TSXV:ADK) looks to promote eye-health awareness through Farmacias Benavides clinics

Brieanna McCutcheon  June 23, 2022

DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance

GlobeNewswire June 23, 2022

DIAGNOS (TSXV:ADK) deploys Age-Related Macular Degeneration detection application

Shoran Devi June 7, 2022